$2.84 +3.16 (111.27%)

Qualigen Therapeutics, Inc. Common Stock (QLGN)

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing innovative diagnostic and therapeutic solutions. The company is known for its work in oncology and infectious disease testing, leveraging advanced technologies to improve patient diagnosis and treatment.

🚫 Qualigen Therapeutics, Inc. Common Stock does not pay dividends

Company News

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction
GlobeNewswire Inc. • Faraday Future • September 19, 2025

Faraday Future will invest $41 million in Qualigen Therapeutics through a PIPE transaction, focusing on crypto and Web3 business, with plans to rebrand the company as CXC10 and gain majority ownership.

Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Benzinga • Avi Kapoor • July 16, 2024

Match Group shares jumped 8% in pre-market trading after Starboard Value took a stake of over 6.5% in the company and is advocating for a potential sale. Several other stocks also saw significant pre-market movement.

Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today
PennyStocks • J. Phillip • April 12, 2022

Check these 3 under $1 biotech penny stocks out for your list The post Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.